Strategic Options
Subscription
By Jon D. Markman On October 16, 202206:30 AM Eastern
Technology investors are dealing with unprecedented bad news, yet Wednesday brought a glimmer of hope. Personalized medicine is getting closer to reality.
Executives at Merck (MRK) announced...
By Jordan Chussler On October 15, 202207:00 AM Eastern
Despite the S&P 500 being down nearly 25% year to date, opportunity abounds if investors know where to look.
By Jon D. Markman On October 14, 202202:43 PM Eastern
Stocks went into a nose-dive after a report showed a rise in U.S. year-ahead inflation expectations.
When inflation is elevated, this asset can keep you afloat.
Weekend Windfalls
Subscription
By Mike Larson, Nilus Mattive, Juan M. Villaverde and Mandeep Rai On October 14, 202211:30 AM Eastern
Why it makes more sense to wait for a clear direction before you do anything new.
By Tony Sagami On October 14, 202209:30 AM Eastern
Mainstream media’s obsessed with Musk’s buyout of Twitter and Tesla’s stock slumped from that attention.
By Tony Sagami On October 14, 202207:00 AM Eastern
Luxury car demand is white-hot, especially for luxury EVs.
Strategic Options
Subscription
By Jon D. Markman On October 14, 202206:30 AM Eastern
Inflation at the consumer level remained hot on Thursday, and traders bought stocks anyway. It didn’t start that way, though. The S&P 500 sank 2% almost immediately after a thicker-than-expected...
Strategic Options
Subscription
By Jon D. Markman On October 13, 202202:53 PM Eastern
Stocks stormed back from losses sparked by a hot inflation reading on speculation the yearlong selloff had potentially reached a bottom.
By Jon D. Markman On October 13, 202210:28 AM Eastern
The pharmaceutical business can be extremely profitable, especially when the technology is cutting edge and deep-pocketed partners abound.